| Drug Name: | Cefmenoxime (65085-01-0) |
|---|---|
| PubChem ID: | 9570757 |
| SMILES: | CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=NOC)/C4=CSC(=N4)N)SC2)C(=O)O |
| InchiKey: | HJJDBAOLQAWBMH-YCRCPZNHSA-N |
| Therapeutic Category: | Anti-Bacterial Agents, Anti-Infective Agents |
| Molecular Weight (dalton) | : | 511.571 |
| LogP | : | -0.8698 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 14 |
| Hydrogen Bond Donor Count | : | 3 |
| Total Polar Surface Area | : | 190.81 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Warfarin (81-81-2) | Bleeding | Additive | Cephalosporins with an N-methylthiotetrazole side-chain can, like the oral anticoagulants, act as vitamin K antagonists to reduce the production of some blood clotting factors. They can therefore cause bleeding on their own. | Influence of cephalosporin antibiotics on blood coagulation and platelet function |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Bacteremia | MetaADEDB |
| Gram-Positive Bacterial Infections | MetaADEDB |
| Meningitis Haemophilus | MetaADEDB |